241 related articles for article (PubMed ID: 20689828)
21. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
[TBL] [Abstract][Full Text] [Related]
22. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
Lahdenranta J; Hagendoorn J; Padera TP; Hoshida T; Nelson G; Kashiwagi S; Jain RK; Fukumura D
Cancer Res; 2009 Apr; 69(7):2801-8. PubMed ID: 19318557
[TBL] [Abstract][Full Text] [Related]
23. Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies.
Shukla GS; Krag DN; Peletskaya EN; Pero SC; Sun YJ; Carman CL; McCahill LE; Roland TA
Cancer Immunol Immunother; 2013 Aug; 62(8):1397-410. PubMed ID: 23736951
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of anti-VEGFR-3 specific scFv antibodies as potential therapeutic and diagnostic tools for tumor lymph-angiogenesis.
Zehnder-Fjällman AH; Marty C; Halin C; Hohn A; Schibli R; Ballmer-Hofer K; Schwendener RA
Oncol Rep; 2007 Oct; 18(4):933-41. PubMed ID: 17786357
[TBL] [Abstract][Full Text] [Related]
25. The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.
Harris NC; Davydova N; Roufail S; Paquet-Fifield S; Paavonen K; Karnezis T; Zhang YF; Sato T; Rothacker J; Nice EC; Stacker SA; Achen MG
J Biol Chem; 2013 Mar; 288(12):8176-8186. PubMed ID: 23404505
[TBL] [Abstract][Full Text] [Related]
26. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
[TBL] [Abstract][Full Text] [Related]
28. [Selection and characterization of human antibodies against vascular endothelial growth factor from human phage display antibody library].
Tian X; Shou C; Dong Z
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):567-70. PubMed ID: 11798817
[TBL] [Abstract][Full Text] [Related]
29. The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding.
Davydova N; Roufail S; Streltsov VA; Stacker SA; Achen MG
J Mol Biol; 2011 Apr; 407(4):581-93. PubMed ID: 21315726
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
Achen MG; Roufail S; Domagala T; Catimel B; Nice EC; Geleick DM; Murphy R; Scott AM; Caesar C; Makinen T; Alitalo K; Stacker SA
Eur J Biochem; 2000 May; 267(9):2505-15. PubMed ID: 10785369
[TBL] [Abstract][Full Text] [Related]
31. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
32. Production of a recombinant anti-human CD4 single-chain variable-fragment antibody using phage display technology and its expression in Escherichia coli.
Babaei A; Zarkesh-Esfahani SH; Gharagozloo M
J Microbiol Biotechnol; 2011 May; 21(5):529-35. PubMed ID: 21617352
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
34. [Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer].
Dong X; Qiu XS; Wang EH; Li QC; Gu W
Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):128-32. PubMed ID: 12839674
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain.
van den Brink EN; Turenhout EA; Bank CM; Fijnvandraat K; Peters M; Voorberg J
Blood; 2000 Jul; 96(2):540-5. PubMed ID: 10887116
[TBL] [Abstract][Full Text] [Related]
36. [Construction of a phage antibody library and screening of anti-epidermal growth factor receptor variant III single chain antibody].
Han DG; Duan XY; Guo YM; Zhou Q; Wang QY; Yang GX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):25-9. PubMed ID: 20117977
[TBL] [Abstract][Full Text] [Related]
37. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
38. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
Hwang-Bo J; Bae MG; Park JH; Chung IS
BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
[TBL] [Abstract][Full Text] [Related]
39. [Affinity maturation of a single chain antibody against VEGFR2 by hydrophilic shuffling].
Qi HD; Miao XN; Zhang J; Gu K; Zhang SW; Wang M
Yao Xue Xue Bao; 2012 Oct; 47(10):1323-8. PubMed ID: 23289144
[TBL] [Abstract][Full Text] [Related]
40. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
